In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 6th, 2004 | 19 | No |
Popular Name: Vorinostat Vorinostat
Find On: PubMed — Wikipedia — Google
CAS Numbers: 149647-78-9 , [149647-78-9]
149647-78-9; D06320; Vorinostat (JAN/USAN); Zolinza (TN)
N'-hydroxy-N-phenyloctanediamide
N-Hydroxy-N'-phenyl octanediamide
N-hydroxy-N'-phenyl-octane-1,8-diotic acid diamide
N-hydroxy-n'-phenyloctanediamide
N-hyrdroxy-n'-phenyloctanediamide
N1-hydroxy-N8-phenyloctanediamide
Octanediamide, N-hydroxy-N'-phenyl-
Octanediamide, N1-hydroxy-N8-phenyl-
OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE
SAHA, MK0683, suberoylanilide hydroxamic acid
SAHA, Suberoylanilide hydroxamic acid
suberoylanilide hydroxamic acid
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.47 | 4.41 | -18.87 | 3 | 5 | 0 | 78 | 264.325 | 8 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 7.16e-02 g/l | DrugBank-approved |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Purity | 97% | Fluorochem |
Therapy | antineoplastic, histone deacetylase inhibitor | SMDC Pharmakon |
UniProt Database Links | AR13B_MOUSE; CDK20_DANRE; CDK20_HUMAN; CDK20_MACMU; CDK20_MOUSE; CDK20_PONAB; CDK20_RAT; CDON_HUMAN; CDON_MOUSE; CDON_RAT; CER1_CHICK; CLUA1_MOUSE; DISP1_MOUSE; FGF4_CHICK; FZD10_CHICK; GDF6B_DANRE; GLI1_CHICK; GLI1_HUMAN; GLI1_MOUSE; GLI1_XENLA; GLI2_CHI | ChEBI |
Indications | cutaneous T-cell lymphoma | KeyOrganics Bioactives |
Target | HDAC | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
HDAH-1-B | Histone Deacetylase-like Amidohydrolase (cluster #1 Of 2), Bacterial | Bacteria | 1300 | 0.43 | Binding ≤ 10μM |
B1WBY8-1-E | Histone Deacetylase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 440 | 0.47 | Binding ≤ 10μM |
HDA10-1-E | Histone Deacetylase 10 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 72 | 0.53 | Binding ≤ 10μM |
HDA11-3-E | Histone Deacetylase 11 (cluster #3 Of 3), Eukaryotic | Eukaryotes | 50 | 0.54 | Binding ≤ 10μM |
HDAC1-3-E | Histone Deacetylase 1 (cluster #3 Of 4), Eukaryotic | Eukaryotes | 440 | 0.47 | Binding ≤ 10μM |
HDAC2-4-E | Histone Deacetylase 2 (cluster #4 Of 4), Eukaryotic | Eukaryotes | 921 | 0.44 | Binding ≤ 10μM |
HDAC3-2-E | Histone Deacetylase 3 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 440 | 0.47 | Binding ≤ 10μM |
HDAC4-2-E | Histone Deacetylase 4 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 440 | 0.47 | Binding ≤ 10μM |
HDAC5-1-E | Histone Deacetylase 5 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 50 | 0.54 | Binding ≤ 10μM |
HDAC6-2-E | Histone Deacetylase 6 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 90 | 0.52 | Binding ≤ 10μM |
HDAC7-3-E | Histone Deacetylase 7 (cluster #3 Of 3), Eukaryotic | Eukaryotes | 440 | 0.47 | Binding ≤ 10μM |
HDAC8-1-E | Histone Deacetylase 8 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 820 | 0.45 | Binding ≤ 10μM |
HDAC9-3-E | Histone Deacetylase 9 (cluster #3 Of 3), Eukaryotic | Eukaryotes | 65 | 0.53 | Binding ≤ 10μM |
NCOR2-1-E | Nuclear Receptor Corepressor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 34 | 0.55 | Binding ≤ 10μM |
Q5RJZ2-1-E | Histone Deacetylase 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 440 | 0.47 | Binding ≤ 10μM |
Q7K6A1-1-E | Histone Deacetylase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 100 | 0.52 | Binding ≤ 10μM |
Q94F81-1-E | Histone Deacetylase HD2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 50 | 0.54 | Binding ≤ 10μM |
Q99P97-1-E | Histone Deacetylase 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 440 | 0.47 | Binding ≤ 10μM |
Q9XYC7-1-E | Histone Deacetylase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 59 | 0.53 | Binding ≤ 10μM |
Q9ZTP8-1-E | Histone Deacetylase HD1B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 30 | 0.55 | Binding ≤ 10μM |
HDA10-1-E | Histone Deacetylase 10 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7200 | 0.38 | Functional ≤ 10μM |
HDA11-1-E | Histone Deacetylase 11 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7200 | 0.38 | Functional ≤ 10μM |
HDAC1-1-E | Histone Deacetylase 1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 7200 | 0.38 | Functional ≤ 10μM |
HDAC2-1-E | Histone Deacetylase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 7200 | 0.38 | Functional ≤ 10μM |
HDAC3-1-E | Histone Deacetylase 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 7200 | 0.38 | Functional ≤ 10μM |
HDAC4-1-E | Histone Deacetylase 4 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 7200 | 0.38 | Functional ≤ 10μM |
HDAC5-1-E | Histone Deacetylase 5 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 7200 | 0.38 | Functional ≤ 10μM |
HDAC6-1-E | Histone Deacetylase 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 7200 | 0.38 | Functional ≤ 10μM |
HDAC7-1-E | Histone Deacetylase 7 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 7200 | 0.38 | Functional ≤ 10μM |
HDAC8-1-E | Histone Deacetylase 8 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 7200 | 0.38 | Functional ≤ 10μM |
HDAC9-1-E | Histone Deacetylase 9 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 7200 | 0.38 | Functional ≤ 10μM |
Q94F81-2-E | Histone Deacetylase HD2 (cluster #2 Of 2), Eukaryotic | Eukaryotes | 50 | 0.54 | Functional ≤ 10μM |
Z102015-1-O | Plasmodium Vivax (cluster #1 Of 1), Other | Other | 170 | 0.50 | Functional ≤ 10μM |
Z103205-2-O | A431 (cluster #2 Of 4), Other | Other | 4200 | 0.40 | Functional ≤ 10μM |
Z103348-2-O | NCI-H2122 (cluster #2 Of 2), Other | Other | 7500 | 0.38 | Functional ≤ 10μM |
Z50136-2-O | Plasmodium Falciparum (isolate FcB1 / Columbia) (cluster #2 Of 3), Other | Other | 820 | 0.45 | Functional ≤ 10μM |
Z50425-5-O | Plasmodium Falciparum (cluster #5 Of 22), Other | Other | 800 | 0.45 | Functional ≤ 10μM |
Z80054-4-O | Caco-2 (Colon Adenocarcinoma Cells) (cluster #4 Of 4), Other | Other | 8100 | 0.38 | Functional ≤ 10μM |
Z80064-7-O | CCRF-CEM (T-cell Leukemia) (cluster #7 Of 9), Other | Other | 950 | 0.44 | Functional ≤ 10μM |
Z80125-1-O | DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other | Other | 2120 | 0.42 | Functional ≤ 10μM |
Z80156-4-O | HL-60 (Promyeloblast Leukemia Cells) (cluster #4 Of 12), Other | Other | 1200 | 0.44 | Functional ≤ 10μM |
Z80164-1-O | HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other | Other | 2400 | 0.41 | Functional ≤ 10μM |
Z80166-4-O | HT-29 (Colon Adenocarcinoma Cells) (cluster #4 Of 12), Other | Other | 2000 | 0.42 | Functional ≤ 10μM |
Z80186-1-O | K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other | Other | 750 | 0.45 | Functional ≤ 10μM |
Z80224-6-O | MCF7 (Breast Carcinoma Cells) (cluster #6 Of 14), Other | Other | 8500 | 0.37 | Functional ≤ 10μM |
Z80244-1-O | MDA-MB-468 (Breast Adenocarcinoma) (cluster #1 Of 7), Other | Other | 5000 | 0.39 | Functional ≤ 10μM |
Z80322-1-O | NCI-H358 (Lung Carcinama Cells) (cluster #1 Of 2), Other | Other | 2500 | 0.41 | Functional ≤ 10μM |
Z80390-3-O | PC-3 (Prostate Carcinoma Cells) (cluster #3 Of 10), Other | Other | 6500 | 0.38 | Functional ≤ 10μM |
Z80418-9-O | RAW264.7 (Monocytic-macrophage Leukemia Cells) (cluster #9 Of 9), Other | Other | 760 | 0.45 | Functional ≤ 10μM |
Z80475-2-O | SK-BR-3 (Breast Adenocarcinoma) (cluster #2 Of 3), Other | Other | 2100 | 0.42 | Functional ≤ 10μM |
Z80493-3-O | SK-OV-3 (Ovarian Carcinoma Cells) (cluster #3 Of 6), Other | Other | 2500 | 0.41 | Functional ≤ 10μM |
Z80513-1-O | SQ20B (cluster #1 Of 1), Other | Other | 3000 | 0.41 | Functional ≤ 10μM |
Z80514-1-O | St-4 (Stomach Carcinoma Cells) (cluster #1 Of 1), Other | Other | 5200 | 0.39 | Functional ≤ 10μM |
Z80682-2-O | A549 (Lung Carcinoma Cells) (cluster #2 Of 11), Other | Other | 868 | 0.45 | Functional ≤ 10μM |
Z80838-1-O | EOL1 (Eosinophilic Cells) (cluster #1 Of 1), Other | Other | 1000 | 0.44 | Functional ≤ 10μM |
Z80857-1-O | Friend Leukemia Cell Line (cluster #1 Of 2), Other | Other | 990 | 0.44 | Functional ≤ 10μM |
Z80874-3-O | CEM (T-cell Leukemia) (cluster #3 Of 7), Other | Other | 1900 | 0.42 | Functional ≤ 10μM |
Z80877-1-O | NCI-H1299 (Non-small Cell Lung Carcinoma) (cluster #1 Of 2), Other | Other | 7240 | 0.38 | Functional ≤ 10μM |
Z80896-1-O | NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other | Other | 2060 | 0.42 | Functional ≤ 10μM |
Z80928-3-O | HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other | Other | 900 | 0.45 | Functional ≤ 10μM |
Z81020-4-O | HepG2 (Hepatoblastoma Cells) (cluster #4 Of 8), Other | Other | 9300 | 0.37 | Functional ≤ 10μM |
Z81024-2-O | NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #2 Of 8), Other | Other | 3448 | 0.40 | Functional ≤ 10μM |
Z81034-3-O | A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other | Other | 2600 | 0.41 | Functional ≤ 10μM |
Z81072-6-O | Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other | Other | 2300 | 0.42 | Functional ≤ 10μM |
Z81170-3-O | LNCaP (Prostate Carcinoma) (cluster #3 Of 5), Other | Other | 580 | 0.46 | Functional ≤ 10μM |
Z81184-5-O | LOX IMVI (Melanoma Cells) (cluster #5 Of 5), Other | Other | 1300 | 0.43 | Functional ≤ 10μM |
Z81245-4-O | MDA-MB-435 (Breast Carcinoma Cells) (cluster #4 Of 6), Other | Other | 1900 | 0.42 | Functional ≤ 10μM |
Z81247-6-O | HeLa (Cervical Adenocarcinoma Cells) (cluster #6 Of 9), Other | Other | 460 | 0.47 | Functional ≤ 10μM |
Z81252-6-O | MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #6 Of 11), Other | Other | 2200 | 0.42 | Functional ≤ 10μM |
Z81280-3-O | NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #3 Of 3), Other | Other | 3480 | 0.40 | Functional ≤ 10μM |
Z81281-4-O | NCI-H23 (Non-small Cell Lung Carcinoma Cells) (cluster #4 Of 5), Other | Other | 383 | 0.47 | Functional ≤ 10μM |
Z81283-1-O | NCI-H522 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 2), Other | Other | 832 | 0.45 | Functional ≤ 10μM |
Z81331-1-O | SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other | Other | 600 | 0.46 | Functional ≤ 10μM |
Z81335-2-O | HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other | Other | 3900 | 0.40 | Functional ≤ 10μM |
Z80957-2-O | HMEC (Microvascular Endothelial Cells) (cluster #2 Of 2), Other | Other | 1300 | 0.43 | ADME/T ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
Q9XYC7_PLAFA | Q9XYC7 | Histone Deacetylase, Plafa | 130 | 0.51 | Binding ≤ 1μM |
Q7K6A1_PLAF7 | Q7K6A1 | Histone Deacetylase, Plaf7 | 100 | 0.52 | Binding ≤ 1μM |
HDAC1_HUMAN | Q13547 | Histone Deacetylase 1, Human | 1.3 | 0.65 | Binding ≤ 1μM |
HDAC1_MOUSE | O09106 | Histone Deacetylase 1, Mouse | 112 | 0.51 | Binding ≤ 1μM |
HDAC1_RAT | Q4QQW4 | Histone Deacetylase 1, Rat | 165 | 0.50 | Binding ≤ 1μM |
HDA10_HUMAN | Q969S8 | Histone Deacetylase 10, Human | 10 | 0.59 | Binding ≤ 1μM |
HDA11_HUMAN | Q96DB2 | Histone Deacetylase 11, Human | 10 | 0.59 | Binding ≤ 1μM |
HDAC2_HUMAN | Q92769 | Histone Deacetylase 2, Human | 1.6 | 0.65 | Binding ≤ 1μM |
B1WBY8_RAT | B1WBY8 | Histone Deacetylase 2, Rat | 165 | 0.50 | Binding ≤ 1μM |
HDAC3_HUMAN | O15379 | Histone Deacetylase 3, Human | 10 | 0.59 | Binding ≤ 1μM |
HDAC3_RAT | Q6P6W3 | Histone Deacetylase 3, Rat | 165 | 0.50 | Binding ≤ 1μM |
HDAC4_HUMAN | P56524 | Histone Deacetylase 4, Human | 10 | 0.59 | Binding ≤ 1μM |
HDAC4_RAT | Q99P99 | Histone Deacetylase 4, Rat | 165 | 0.50 | Binding ≤ 1μM |
HDAC5_HUMAN | Q9UQL6 | Histone Deacetylase 5, Human | 10 | 0.59 | Binding ≤ 1μM |
Q5RJZ2_RAT | Q5RJZ2 | Histone Deacetylase 5, Rat | 165 | 0.50 | Binding ≤ 1μM |
HDAC6_HUMAN | Q9UBN7 | Histone Deacetylase 6, Human | 1 | 0.66 | Binding ≤ 1μM |
Q99P97_RAT | Q99P97 | Histone Deacetylase 6, Rat | 165 | 0.50 | Binding ≤ 1μM |
HDAC7_RAT | Q99P96 | Histone Deacetylase 7, Rat | 165 | 0.50 | Binding ≤ 1μM |
HDAC7_HUMAN | Q8WUI4 | Histone Deacetylase 7, Human | 10 | 0.59 | Binding ≤ 1μM |
HDAC8_HUMAN | Q9BY41 | Histone Deacetylase 8, Human | 10 | 0.59 | Binding ≤ 1μM |
HDAC9_HUMAN | Q9UKV0 | Histone Deacetylase 9, Human | 10 | 0.59 | Binding ≤ 1μM |
Q9ZTP8_MAIZE | Q9ZTP8 | Histone Deacetylase HD1B, Maize | 28 | 0.56 | Binding ≤ 1μM |
Q94F81_MAIZE | Q94F81 | Histone Deacetylase HD2, Maize | 1000 | 0.44 | Binding ≤ 1μM |
HDAH_ALCSD | Q70I53 | Histone Deacetylase-like Amidohydrolase, Alcsd | 1000 | 0.44 | Binding ≤ 1μM |
NCOR2_HUMAN | Q9Y618 | Nuclear Receptor Corepressor 2, Human | 18.8 | 0.57 | Binding ≤ 1μM |
Q9XYC7_PLAFA | Q9XYC7 | Histone Deacetylase, Plafa | 130 | 0.51 | Binding ≤ 10μM |
Q7K6A1_PLAF7 | Q7K6A1 | Histone Deacetylase, Plaf7 | 100 | 0.52 | Binding ≤ 10μM |
HDAC1_RAT | Q4QQW4 | Histone Deacetylase 1, Rat | 165 | 0.50 | Binding ≤ 10μM |
HDAC1_HUMAN | Q13547 | Histone Deacetylase 1, Human | 1.3 | 0.65 | Binding ≤ 10μM |
HDAC1_MOUSE | O09106 | Histone Deacetylase 1, Mouse | 112 | 0.51 | Binding ≤ 10μM |
HDA10_HUMAN | Q969S8 | Histone Deacetylase 10, Human | 10 | 0.59 | Binding ≤ 10μM |
HDA11_HUMAN | Q96DB2 | Histone Deacetylase 11, Human | 10 | 0.59 | Binding ≤ 10μM |
HDAC2_HUMAN | Q92769 | Histone Deacetylase 2, Human | 1.6 | 0.65 | Binding ≤ 10μM |
B1WBY8_RAT | B1WBY8 | Histone Deacetylase 2, Rat | 165 | 0.50 | Binding ≤ 10μM |
HDAC3_RAT | Q6P6W3 | Histone Deacetylase 3, Rat | 165 | 0.50 | Binding ≤ 10μM |
HDAC3_HUMAN | O15379 | Histone Deacetylase 3, Human | 10 | 0.59 | Binding ≤ 10μM |
HDAC4_RAT | Q99P99 | Histone Deacetylase 4, Rat | 165 | 0.50 | Binding ≤ 10μM |
HDAC4_HUMAN | P56524 | Histone Deacetylase 4, Human | 10 | 0.59 | Binding ≤ 10μM |
Q5RJZ2_RAT | Q5RJZ2 | Histone Deacetylase 5, Rat | 165 | 0.50 | Binding ≤ 10μM |
HDAC5_HUMAN | Q9UQL6 | Histone Deacetylase 5, Human | 10 | 0.59 | Binding ≤ 10μM |
Q99P97_RAT | Q99P97 | Histone Deacetylase 6, Rat | 165 | 0.50 | Binding ≤ 10μM |
HDAC6_HUMAN | Q9UBN7 | Histone Deacetylase 6, Human | 1 | 0.66 | Binding ≤ 10μM |
HDAC7_RAT | Q99P96 | Histone Deacetylase 7, Rat | 165 | 0.50 | Binding ≤ 10μM |
HDAC7_HUMAN | Q8WUI4 | Histone Deacetylase 7, Human | 10 | 0.59 | Binding ≤ 10μM |
HDAC8_HUMAN | Q9BY41 | Histone Deacetylase 8, Human | 10 | 0.59 | Binding ≤ 10μM |
HDAC9_HUMAN | Q9UKV0 | Histone Deacetylase 9, Human | 10 | 0.59 | Binding ≤ 10μM |
Q9ZTP8_MAIZE | Q9ZTP8 | Histone Deacetylase HD1B, Maize | 28 | 0.56 | Binding ≤ 10μM |
Q94F81_MAIZE | Q94F81 | Histone Deacetylase HD2, Maize | 1000 | 0.44 | Binding ≤ 10μM |
HDAH_ALCSD | Q70I53 | Histone Deacetylase-like Amidohydrolase, Alcsd | 1000 | 0.44 | Binding ≤ 10μM |
NCOR2_HUMAN | Q9Y618 | Nuclear Receptor Corepressor 2, Human | 18.8 | 0.57 | Binding ≤ 10μM |
Z81034 | Z81034 | A2780 (Ovarian Carcinoma Cells) | 1620 | 0.43 | Functional ≤ 10μM |
Z103205 | Z103205 | A431 | 4200 | 0.40 | Functional ≤ 10μM |
Z80682 | Z80682 | A549 (Lung Carcinoma Cells) | 1800 | 0.42 | Functional ≤ 10μM |
Z80054 | Z80054 | Caco-2 (Colon Adenocarcinoma Cells) | 8100 | 0.38 | Functional ≤ 10μM |
Z80064 | Z80064 | CCRF-CEM (T-cell Leukemia) | 800 | 0.45 | Functional ≤ 10μM |
Z80874 | Z80874 | CEM (T-cell Leukemia) | 1900 | 0.42 | Functional ≤ 10μM |
Z80125 | Z80125 | DU-145 (Prostate Carcinoma) | 1600 | 0.43 | Functional ≤ 10μM |
Z80838 | Z80838 | EOL1 (Eosinophilic Cells) | 1000 | 0.44 | Functional ≤ 10μM |
Z80857 | Z80857 | Friend Leukemia Cell Line | 990 | 0.44 | Functional ≤ 10μM |
Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 1000 | 0.44 | Functional ≤ 10μM |
Z81335 | Z81335 | HCT-15 (Colon Adenocarcinoma Cells) | 3900 | 0.40 | Functional ≤ 10μM |
Z81247 | Z81247 | HeLa (Cervical Adenocarcinoma Cells) | 1500 | 0.43 | Functional ≤ 10μM |
Z81020 | Z81020 | HepG2 (Hepatoblastoma Cells) | 0.6 | 0.68 | Functional ≤ 10μM |
HDAC1_HUMAN | Q13547 | Histone Deacetylase 1, Human | 125 | 0.51 | Functional ≤ 10μM |
HDA10_HUMAN | Q969S8 | Histone Deacetylase 10, Human | 7200 | 0.38 | Functional ≤ 10μM |
HDA11_HUMAN | Q96DB2 | Histone Deacetylase 11, Human | 7200 | 0.38 | Functional ≤ 10μM |
HDAC2_HUMAN | Q92769 | Histone Deacetylase 2, Human | 28 | 0.56 | Functional ≤ 10μM |
HDAC3_HUMAN | O15379 | Histone Deacetylase 3, Human | 28 | 0.56 | Functional ≤ 10μM |
HDAC4_HUMAN | P56524 | Histone Deacetylase 4, Human | 178 | 0.50 | Functional ≤ 10μM |
HDAC5_HUMAN | Q9UQL6 | Histone Deacetylase 5, Human | 178 | 0.50 | Functional ≤ 10μM |
HDAC6_HUMAN | Q9UBN7 | Histone Deacetylase 6, Human | 7200 | 0.38 | Functional ≤ 10μM |
HDAC7_HUMAN | Q8WUI4 | Histone Deacetylase 7, Human | 178 | 0.50 | Functional ≤ 10μM |
HDAC8_HUMAN | Q9BY41 | Histone Deacetylase 8, Human | 28 | 0.56 | Functional ≤ 10μM |
HDAC9_HUMAN | Q9UKV0 | Histone Deacetylase 9, Human | 178 | 0.50 | Functional ≤ 10μM |
Q94F81_MAIZE | Q94F81 | Histone Deacetylase HD2, Maize | 50 | 0.54 | Functional ≤ 10μM |
Z80156 | Z80156 | HL-60 (Promyeloblast Leukemia Cells) | 1200 | 0.44 | Functional ≤ 10μM |
Z80164 | Z80164 | HT-1080 (Fibrosarcoma Cells) | 2.4 | 0.64 | Functional ≤ 10μM |
Z80166 | Z80166 | HT-29 (Colon Adenocarcinoma Cells) | 2000 | 0.42 | Functional ≤ 10μM |
Z81072 | Z81072 | Jurkat (Acute Leukemic T-cells) | 2300 | 0.42 | Functional ≤ 10μM |
Z80186 | Z80186 | K562 (Erythroleukemia Cells) | 2200 | 0.42 | Functional ≤ 10μM |
Z81170 | Z81170 | LNCaP (Prostate Carcinoma) | 1000 | 0.44 | Functional ≤ 10μM |
Z81184 | Z81184 | LOX IMVI (Melanoma Cells) | 1300 | 0.43 | Functional ≤ 10μM |
Z80224 | Z80224 | MCF7 (Breast Carcinoma Cells) | 1150 | 0.44 | Functional ≤ 10μM |
Z81252 | Z81252 | MDA-MB-231 (Breast Adenocarcinoma Cells) | 1180 | 0.44 | Functional ≤ 10μM |
Z81245 | Z81245 | MDA-MB-435 (Breast Carcinoma Cells) | 1900 | 0.42 | Functional ≤ 10μM |
Z80244 | Z80244 | MDA-MB-468 (Breast Adenocarcinoma) | 1300 | 0.43 | Functional ≤ 10μM |
Z80877 | Z80877 | NCI-H1299 (Non-small Cell Lung Carcinoma) | 550 | 0.46 | Functional ≤ 10μM |
Z103348 | Z103348 | NCI-H2122 | 7500 | 0.38 | Functional ≤ 10μM |
Z81280 | Z81280 | NCI-H226 (Non-small Cell Lung Carcinoma Cells) | 2600 | 0.41 | Functional ≤ 10μM |
Z81281 | Z81281 | NCI-H23 (Non-small Cell Lung Carcinoma Cells) | 383 | 0.47 | Functional ≤ 10μM |
Z80322 | Z80322 | NCI-H358 (Lung Carcinama Cells) | 2500 | 0.41 | Functional ≤ 10μM |
Z81024 | Z81024 | NCI-H460 (Non-small Cell Lung Carcinoma) | 3448 | 0.40 | Functional ≤ 10μM |
Z81283 | Z81283 | NCI-H522 (Non-small Cell Lung Carcinoma Cells) | 832 | 0.45 | Functional ≤ 10μM |
Z80896 | Z80896 | NCI-H69 (Small Cell Lung Carcinoma Cells) | 2060 | 0.42 | Functional ≤ 10μM |
Z80390 | Z80390 | PC-3 (Prostate Carcinoma Cells) | 1210 | 0.44 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 109.7 | 0.51 | Functional ≤ 10μM |
Z50136 | Z50136 | Plasmodium Falciparum (isolate FcB1 / Columbia) | 820 | 0.45 | Functional ≤ 10μM |
Z102015 | Z102015 | Plasmodium Vivax | 147 | 0.50 | Functional ≤ 10μM |
Z80418 | Z80418 | RAW264.7 (Monocytic-macrophage Leukemia Cells) | 1880 | 0.42 | Functional ≤ 10μM |
Z80475 | Z80475 | SK-BR-3 (Breast Adenocarcinoma) | 1190 | 0.44 | Functional ≤ 10μM |
Z80493 | Z80493 | SK-OV-3 (Ovarian Carcinoma Cells) | 2200 | 0.42 | Functional ≤ 10μM |
Z80513 | Z80513 | SQ20B | 3000 | 0.41 | Functional ≤ 10μM |
Z80514 | Z80514 | St-4 (Stomach Carcinoma Cells) | 5200 | 0.39 | Functional ≤ 10μM |
Z81331 | Z81331 | SW-620 (Colon Adenocarcinoma Cells) | 600 | 0.46 | Functional ≤ 10μM |
Z80957 | Z80957 | HMEC (Microvascular Endothelial Cells) | 1300 | 0.43 | ADME/T ≤ 10μM |
Description | Species |
---|---|
BMAL1:CLOCK,NPAS2 activates circadian gene expression | |
Circadian Clock | |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | |
Constitutive Signaling by NOTCH1 PEST Domain Mutants | |
deactivation of the beta-catenin transactivating complex | |
Downregulation of SMAD2/3:SMAD4 transcriptional activity | |
Factors involved in megakaryocyte development and platelet production | |
formation of the beta-catenin:TCF transactivating complex | |
G0 and Early G1 | |
HDACs deacetylate histones | |
HSF1 activation | |
NoRC negatively regulates rRNA expression | |
NOTCH1 Intracellular Domain Regulates Transcription | |
p75NTR negatively regulates cell cycle via SC1 | |
PPARA activates gene expression | |
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alp | |
repression of WNT target genes | |
REV-ERBA represses gene expression | |
RNA Polymerase I Transcription Initiation | |
RORA activates circadian gene expression | |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | |
Transcriptional activation of mitochondrial biogenesis | |
Transcriptional regulation of white adipocyte differentiation |